DuPont has revealed plans to acquire Donatelle Plastics Incorporated, a prominent contract manufacturer in the medical device sector specializing in the design, development, and production of medical components and devices.

The transaction is expected to close in the third quarter of 2024, pending the fulfillment of standard closing conditions and regulatory approvals.

"Our healthcare strategy is focused on providing a complete range of solutions tailored to high-growth therapeutic areas."

"Adding Donatelle Plastics Incorporated to our portfolio, following our acquisition of Spectrum last year, will enhance our expertise in medical device market segments and solidify our standing as a trusted partner for our customers."

Within DuPont's Industrial Solutions division of the E&I segment, the healthcare portfolio includes Spectrum, a leader in medical device components, and Liveo™, known for silicone solutions in healthcare applications.

The acquisition of Donatelle Plastics Incorporated will introduce complementary advanced technologies and capabilities, spanning medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool manufacturing.

Donatelle Plastics Incorporated has shown a strong financial growth trajectory aligned with promising therapeutic sectors such as electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities.

Founded in 1967 and based in New Brighton, Minnesota, Donatelle Plastics Incorporated employs over 400 professionals and operates a facility strategically positioned within a hub of medical technology near major original equipment manufacturers.

Over the years, Donatelle has built lasting partnerships through superior customer service, exceptional quality, and expertise in injection molding.

The company is renowned for its innovative approach to manufacturing medical devices and components, particularly in applications requiring high standards of quality, reliability, and technical proficiency.

"We're looking forward to the next phase of Donatelle's evolution and for our team of exceptionally talented employees to become part of DuPont.

"Within DuPont’s expansive healthcare portfolio, we expect to significantly impact patient outcomes by fostering innovation and advancing next-generation devices for patients worldwide."

 

 

 

 

 

 

Source: dupont.com

Report Abuse